Results 11 to 20 of about 107,795 (308)

Granulocyte colony‐stimulating factor producing retroperitoneal leiomyosarcoma

IJU Case Reports, 2021
Introduction Granulocyte colony‐stimulating factor‐producing nonhematopoietic malignancies have poor clinical outcomes. Case presentation A 62‐year‐old woman complaining of fever and left lower quadrant pain was referred to our hospital.
Kyotaro Fukuta, Kei Daizumoto, Masayuki Takahashi, Hidehisa Mori, Yoichi Otomi, Hisanori Uehara, Tomoya Fukawa, Yasuyo Yamamoto, Kunihisa Yamaguchi, Hiro‐omi Kanayama   +9 more
doaj   +1 more source

Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report

Journal of Medical Case Reports, 2008
Introduction The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare.
Nakajima Atsushi, Takahashi Hirokazu, Inamori Masahiko, Abe Yasunobu, Kobayashi Noritoshi, Kubota Kensuke, Yamanaka Shoji   +6 more
doaj   +1 more source

Favorable response to pembrolizumab in granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma

IJU Case Reports, 2022
Introduction Granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma is rare, with a poor prognosis. Advanced urothelial carcinoma is currently treated with immune checkpoint inhibitors, whose efficacy for granulocyte ...
Hiroki Takeda, Ryuji Matsumoto, Emi Takakuwa, Kanta Hori, Takuya Moriguchi, Shuhei Yamada, Hiroshi Kikuchi, Takahiro Osawa, Takashige Abe, Nobuo Shinohara   +9 more
doaj   +1 more source

Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor

Journal of the American College of Cardiology, 2005
Two studies in this issue of the Journal report the effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) to promote coronary neovascularization; both were stopped early because of ominous results. In the report by Zbinden et al. ([1][
Robert F. Wilson, Timothy D. Henry
openaire   +2 more sources

Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes

Tumor Biology, 2017
Granulocyte-macrophage colony-stimulating factor has been widely used as an adjuvant therapy for cancer patients exhibiting myelosuppression induced by chemotherapy or radiotherapy. However, the effects of granulocyte-macrophage colony-stimulating factor
Qiaowei Zheng, Xueqian Li, Xiaoliang Cheng, Ting Cui, Yingcheng Zhuo, Wenbin Ma, Xue Zhao, Peipei Zhao, Xuanlin Liu, Weiyi Feng   +9 more
doaj   +1 more source

The Potential Role of Recombinant Hematopoietic Colony-Stimulating Factors in Preventing Infections in the Immunocompromised Host

Canadian Journal of Infectious Diseases, 1991
Hematopoietic colony-stimulating factors coordinate the proliferation and maturation of bone marrow and peripheral blood cells during normal hematopoiesis.
James Rusthoven
doaj   +1 more source

Granulocyte colony-stimulating factor and its receptor [PDF]

Blood, 1991
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein of Mr of about 20,000, which stimulates proliferation and differentiation of progenitor cells of neutrophils. Recent clinical application of G-CSF has proven that this hormone is effective in treatment of patients suffering from neutropenia.
James D. Griffin, George D. Demetri
openaire   +6 more sources

Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells

Haematologica, 2012
Background Although mobilization of hematopoietic stem cells and hematopoietic progenitor cells can be achieved with a combination of granulocyte colony-stimulating factor and plerixafor (AMD3100), improving approaches for hematopoietic progenitor cell ...
Fabio Di Giacomo, Daniel Lewandowski, Eric Cabannes, Vanessa Nancy-Portebois, Maurice Petitou, Serge Fichelson, Paul-Henri Romeo   +6 more
doaj   +1 more source

Dexamethasone and granulocyte colony-stimulating factor alter the representation of cellular patterns and neurotisation of regenerative neuroma

Patologìâ, 2023
Aim. To evaluate the changes in the total cellularity (Nuc) of the rat sciatic nerve regenerative neuroma (RegN) and its representation of CD90, CD44, CD146, and CD133 positive cells, as well as its neurotization under the conditions of dexamethasone ...
O. M. Grabovyi, N. M. Nevmerzhytska, O. B. Alyokhin, H. B. Kostynskyi, H. Yu. Kondaurova   +4 more
doaj   +1 more source

Regulation of granulocyte colony-stimulating factor and granulocyte- macrophage colony-stimulating factor expression by oncostatin M [PDF]

Blood, 1993
Oncostatin M (OM) is structurally and functionally related to a subclass of hematopoietic cytokines including leukemia-inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), granulocyte colony- stimulating factor (G-CSF), and interleukin-6 (IL-6).
C Brashem-Stein, Mohammed Shoyab, Jingwen Liu, TJ Brown   +3 more
openaire   +3 more sources